Julius Baer reported lower profits for the first half of 2024 as a rise in client assets and activity was offset by higher interest expenses.
Related Posts
Ski-Doo Maker BRP Looks to Shed Struggling Marine Brands
Sea-Doo and Ski-Doo maker BRP said it intends to sell off the majority of its marine businesses, which have been weighed down by softer consumer […]
Merck Buying Drug Targeting B-Cell Diseases for Up to $1.3 Billion
Merck has struck a deal worth up to $1.3 billion to buy an investigational drug targeting B-cell associated diseases.
Energy & Utilities Roundup: Market Talk
Find insight on oil futures, Woodside Energy, Canadian energy companies and more in the latest Market Talks covering Energy and Utilities.